The role of the precursor HIV-1 protease in drug resistance.
- Institution
- Case Western Reserve University, OH
- Principal investigator
- John Christian Tilton
- Funding
- $508K
- Duration
- 2025–2029
Moonbase score
Still being scored
Abstract
Project Abstract This project aims to determine whether the precursor HIV-1 protease (PR) plays an important role in the development of drug resistance to protease inhibitors (PIs). The precursor PR dimer is far less susceptible to inhibition by PIs than the mature PR dimer, leading to the hypothesis that drug resistance mutations may evolve through the relative resistance of the precursor PR. Using innovative techniques ‘locking’ PR in the precursor configuration, we have unexpectedly found that viruses can mature, fuse with target cells, and replicate without formation of mature PR, providing a clear path through which drug resistance can evolve. Aim 1: Assess how mutations within PR or the p6*-PR cleavage site influence dimerization and activity of the precursor and mature PR enzymes. Aim 2: Assess whether PI resistance that develops without canonical mutations in PR alters dimerization and precursor or mature PR function. Aim 3: Perform in vitro viral propagation experiments to better understand how the precursor PR contributes to drug resistance.
LOADING MOONBASE SCORE
Questions for Case Western Reserve University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Case Western Reserve UniversityNot yet scored
Core E: Viral Pathogenesis & Persistence
John Christian Tilton · $198K · 1997–2027
- NIH · Case Western Reserve University60
Targeted Neuroplasticity via vagus nerve stimulation to improve urinary dysfunction after spinal cord injury
Ana Hernandez-Reynoso · $249K · 2023–2028
- NIH · Case Western Reserve University51
Deubiquitinase USP19 in TDP-43 pathogenesis.
David E Kang · $596K · 2022–2027